Our SR HCC model was constructed in vitro, and omics data revealed significant changes in lipid metabolism pathways, while no significant changes were observed in angiogenic signals (such as VEGF, PDGF, FGF, etc). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.